Boryung Pharm Capital Reinvestment Ratio
Boryung Pharm capital reinvestment ratio. Boryung Pharm (003850) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩48.95 Billion) in capital expenditures (₩4.92 Billion). Check cash flow reinvestment rate of Boryung Pharm to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Boryung Pharm (2009–2024)
Capital reinvestment ratio of Boryung Pharm from 2009 to 2024. This chart tracks Boryung Pharm's Capital Reinvestment Ratio across 12 annual periods. Also explore Boryung Pharm (003850) equity growth momentum to track the company's year-over-year net asset growth rate.
Boryung Pharm Capital Reinvestment Ratio by Year (2009–2024)
Boryung Pharm capital reinvestment ratio by year from 2009 to 2024. For the full cash flow conversion analysis, see 003850 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩80.56 Billion | ₩20.05 Billion | ▼ -55.0% |
| 2023 | 0.55x | ₩42.22 Billion | ₩23.35 Billion | ▼ -24.1% |
| 2022 | 0.73x | ₩27.81 Billion | ₩20.28 Billion | ▲ +171.9% |
| 2021 | 0.27x | ₩60.17 Billion | ₩16.13 Billion | ▼ -34.3% |
| 2020 | 0.41x | ₩44.74 Billion | ₩18.27 Billion | ▼ -71.4% |
| 2019 | 1.43x | ₩47.00 Billion | ₩67.02 Billion | ▲ +1.2% |
| 2018 | 1.41x | ₩38.91 Billion | ₩54.83 Billion | ▼ -50.8% |
| 2016 | 2.87x | ₩9.36 Billion | ₩26.83 Billion | ▲ +427.9% |
| 2012 | 0.54x | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩9.19 Billion | ₩14.16 Billion | ▲ +24.9% |
| 2010 | 1.23x | ₩24.12 Billion | ₩29.77 Billion | ▼ -60.7% |
| 2009 | 3.14x | ₩3.59 Billion | ₩11.28 Billion | — |